Abstract
TRPA1 is a member of a superfamily of non-selective cation channels that is known to be involved in multiple physiological functions. TRPA1 is activated by a broad spectrum of chemical irritants and endogenous inflammatory compounds. An emerging role for TRPA1 in mediating pain and inflammation raises the possibility that compounds targeting TRPA1 might have significant therapeutic potential. This review discusses the broad classes of molecules that are known to act as agonists and antagonists of TRPA1 towards the aim of providing an overview of the structure and activity of TRPA1 modulators.
Keywords: Transient receptor potential, TRP channel, TRPA1, pain, asthma, inflammatory, non-selective cation channels, broad spectrum of chemical irritants, endogenous inflammatory compounds, inflammation raises, therapeutic potential, agonists, antagonists, TRPA1 modulators, genomic analysis
Current Topics in Medicinal Chemistry
Title: Transient Receptor Potential A1 Modulators
Volume: 11 Issue: 17
Author(s): Tim Strassmaier and Rajagopal Bakthavatchalam
Affiliation:
Keywords: Transient receptor potential, TRP channel, TRPA1, pain, asthma, inflammatory, non-selective cation channels, broad spectrum of chemical irritants, endogenous inflammatory compounds, inflammation raises, therapeutic potential, agonists, antagonists, TRPA1 modulators, genomic analysis
Abstract: TRPA1 is a member of a superfamily of non-selective cation channels that is known to be involved in multiple physiological functions. TRPA1 is activated by a broad spectrum of chemical irritants and endogenous inflammatory compounds. An emerging role for TRPA1 in mediating pain and inflammation raises the possibility that compounds targeting TRPA1 might have significant therapeutic potential. This review discusses the broad classes of molecules that are known to act as agonists and antagonists of TRPA1 towards the aim of providing an overview of the structure and activity of TRPA1 modulators.
Export Options
About this article
Cite this article as:
Strassmaier Tim and Bakthavatchalam Rajagopal, Transient Receptor Potential A1 Modulators, Current Topics in Medicinal Chemistry 2011; 11 (17) . https://dx.doi.org/10.2174/156802611796904915
DOI https://dx.doi.org/10.2174/156802611796904915 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Can Group Exercise Programs Improve Health Outcomes in Pregnant Women? A Systematic Review
Current Women`s Health Reviews Current Status of Knowledge and Awareness of Diabetes Mellitus in Saudi Arabia
Current Diabetes Reviews Fc Engineering to Improve the Function of Therapeutic Antibodies
Current Pharmaceutical Biotechnology Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy
Current Drug Targets Long Noncoding RNAs as Diagnostic and Therapeutic Targets for Ischemic Stroke
Current Pharmaceutical Design Oxidative Stress in Essential Hypertension
Current Pharmaceutical Design The Pathogenic Subpopulation of Th17 Cells in Obesity
Current Pharmaceutical Design Relationship Between Hypertension and Atherosclerosis: From a Viewpoint of the Most Potent Vasoconstrictor Human Urotensin II
Current Hypertension Reviews The Role of TNF and Its Family Members in Inflammation and Cancer: Lessons from Gene Deletion
Current Drug Targets - Inflammation & Allergy Anti-Diabetic Effect of a Flavonoid and Sitosterol - Rich Aqueous Extract of <i>Pleurotus tuberregium</i> Sclerotia in Alloxan-Induced Diabetic Rabbits
Endocrine, Metabolic & Immune Disorders - Drug Targets An Update on Clinical and Pharmacological Aspects of Drug-Eluting Stents
Cardiovascular & Hematological Disorders-Drug Targets In Utero Exposure to Phthalates and Fetal Development
Current Medicinal Chemistry Geriatric Psychopharmacology in Acute Settings
Current Psychopharmacology Models of Infection Before and After Stroke: Investigating New Targets
Infectious Disorders - Drug Targets Oxidative Stress and Mitochondrial Impairment After Treatment with Anti-HIV Drugs: Clinical Implications
Current Pharmaceutical Design Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
Current Drug Targets Pharmacological Treatments for Obesity-Related Hypertension
Current Hypertension Reviews The Promise of Plant-Derived Substances as Inhibitors of Arginase
Mini-Reviews in Medicinal Chemistry Cardiovascular Disease in the Rheumatic Diseases: How Systemic Inflammation May Contribute to Atherogenesis
Current Rheumatology Reviews Patient, System and Clinician Level Interventions to Address Disparities in Diabetes Care
Current Diabetes Reviews